Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Zhang, Li, Prof, Huang, Yan, MD, Hong, Shaodong, MD, Yang, Yunpeng, MD, Yu, Gengsheng, MD, Jia, Jun, MD, Peng, Peijian, MD, Wu, Xuan, MD, Lin, Qing, Prof, Xi, Xuping, Prof, Peng, Jiewen, MD, Xu, Mingjun, MD, Chen, Dongping, Prof, Lu, Xiaojun, MD, Wang, Rensheng, MD, Cao, Xiaolong, MD, Chen, Xiaozhong, MD, Lin, Zhixiong, Prof, Xiong, Jianping, MD, Lin, Qin, MD, Xie, Conghua, MD, Li, Zhihua, MD, Pan, Jianji, Prof, Li, Jingao, MD, Wu, Shixiu, Prof, Lian, Yingni, MD, Yang, Quanlie, MD, Zhao, Chong, Prof
Published in The Lancet (British edition) (15.10.2016)
Published in The Lancet (British edition) (15.10.2016)
Get full text
Journal Article